Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS
Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS
Recruiting · NCT06126315 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Phase 2 / Phase 3 | 2026-10-06 | NCT06126315 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| FightMND | 2 |
| Mario Negri Institute for Pharmacological Research | 51 |
| University of Sydney | 73 |
19 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.